- Home
- PERI vs ORGO Comparison
PERI vs ORGO Comparison
Compare PERI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PERI | ORGO |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 412.5M | 624.4M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | PERI | ORGO |
|---|---|---|
| Price | $9.93 | $4.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $14.75 | $8.00 |
| AVG Volume (30 Days) | 277.5K | ★ 1.5M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $432,361,000.00 | ★ $465,218,000.00 |
| Revenue This Year | N/A | $8.14 |
| Revenue Next Year | $8.59 | $6.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.24 |
| 52 Week Low | $7.00 | $2.61 |
| 52 Week High | $11.79 | $7.08 |
Technical Indicators
Market Signals| Indicator | PERI | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 46.12 |
| Support Level | $10.03 | $4.61 |
| Resistance Level | $10.24 | $5.83 |
| Average True Range (ATR) | 0.21 | 0.22 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 38.61 | 21.05 |
Price Performance
Historical ComparisonAbout PERI Perion Network Ltd.
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.